Clinical Study for the Treatment of Breast Cancer: the Patient Will Receive Afatinib Plus Letrozole or Letrozole Alone

PHASE2TerminatedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

November 30, 2018

Study Completion Date

November 30, 2018

Conditions
Breast Neoplasms
Interventions
DRUG

Letrozole

DRUG

Afatinib

Trial Locations (26)

11408

Hospital de Especialidades de Jerez de La Frontera, Jerez de la Frontera

15006

Complexo Hospitalario Universitario A Coruña, A Coruña

28806

Hope Women's Cancer Centers, Asheville

30120

Hospital Clínico Universitario Virgen de La Arrixaca, Murcia

32806

Orlando Health, Inc., Orlando

43204

Hospital Universitari de Sant Joan de Reus, Reus

50009

Hospital Universitario Miguel Servet, Zaragoza

71000

Clinical Center of University in Sarajevo, Clinic for Oncology, Sarajevo

75000

University Clinical Center Tuzla Clinic for Oncology, Hematology and Radiotherapy, Tuzla

78000

University Hospital Clinical Center Banja Luka, Oncology Clinic, Banja Luka

89169

Comprehensive Cancer Centers of Nevada, Las Vegas

90095

University of California Los Angeles Hematology Oncology, Los Angeles

90277

DBA Torrance Memorial Physician Network/Cancer Care Associates, Redondo Beach

91328

West Valley Hematology Oncology Medical Group, Northridge

92835

St. Jude Heritage Healthcare, Fullerton

93401

Coastal Integrative Cancer Care, San Luis Obispo

93454

Central Coast Medical Oncology Corporation, Santa Maria

100337

County Hospital Ploiesti, Ploieşti

400006

County Emergency Clinical Hospital Cluj-Napoca Oncology Department, Cluj-Napoca

400058

SC Medisprof SRL, Cluj-Napoca

720237

"County Emergency Hospital Sf Ioan cel Nou", Suceava

Unknown

Filantropia Clinical Hospital, Bucharest

Oncomed SRL Timisoara, Timișoara

02006

Complejo Hospitalario Universitario de Albacete, Albacete

03010

Hospital General Universitario de Alicante, Alicante

07198

Hospital Son Llatzer, Palma de Mallorca

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Boehringer Ingelheim

INDUSTRY

lead

Translational Research in Oncology

OTHER